Trial Outcomes & Findings for Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557) (NCT NCT01181778)

NCT ID: NCT01181778

Last Updated: 2022-02-04

Results Overview

Before receiving counseling, participants recorded on a questionnaire the method of contraception they thought they would choose. This was to be compared with the method of contraception the same participants thought they would choose after they received physician counseling, which was also recorded on their questionnaire.

Recruitment status

COMPLETED

Target enrollment

1919 participants

Primary outcome timeframe

Day of inclusion (Day 0) prior to physician counseling and after physician counseling

Results posted on

2022-02-04

Participant Flow

Participant milestones

Participant milestones
Measure
All Participants
All participants who were enrolled in the study
Overall Study
STARTED
1919
Overall Study
COMPLETED
1871
Overall Study
NOT COMPLETED
48

Reasons for withdrawal

Reasons for withdrawal
Measure
All Participants
All participants who were enrolled in the study
Overall Study
Physician Decision
48

Baseline Characteristics

Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Participants
n=1919 Participants
All participants who were enrolled in the study
Age, Continuous
26.6 years
STANDARD_DEVIATION 6.3 • n=5 Participants
Sex: Female, Male
Female
1919 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day of inclusion (Day 0) prior to physician counseling and after physician counseling

Population: The analysis population consisted of all participants who completed questionnaires before and after physician counseling and had no medical reason to prevent them from using a combined hormonal contraception method.

Before receiving counseling, participants recorded on a questionnaire the method of contraception they thought they would choose. This was to be compared with the method of contraception the same participants thought they would choose after they received physician counseling, which was also recorded on their questionnaire.

Outcome measures

Outcome measures
Measure
All Qualified Participants Before Counseling
n=1871 Participants
Before counseling: All healthy women who were eligible for primary and secondary outcome measure analysis, based on the physician's assessment
All Qualified Participants After Counseling
n=1871 Participants
After counseling: All healthy women who were eligible for primary and secondary outcome measure analysis, based on the physician's assessment
Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling
Weekly Patch
60 Participants
131 Participants
Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling
Daily Pill
1207 Participants
1199 Participants
Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling
Monthy Ring
97 Participants
397 Participants
Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling
Other Method
171 Participants
104 Participants
Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling
Undecided
336 Participants
40 Participants

SECONDARY outcome

Timeframe: Up to four months after the counseling visit

Population: The analysis population consisted of all participants who completed questionnaires before and after physician counseling and had no medical reason to prevent them from using a combined hormonal contraception method.

Participant contacts with physician offices were collected, and the number of callbacks by method of contraception recorded. Participants who called back more than once were counted overall and for each method of contraception.

Outcome measures

Outcome measures
Measure
All Qualified Participants Before Counseling
n=1871 Participants
Before counseling: All healthy women who were eligible for primary and secondary outcome measure analysis, based on the physician's assessment
All Qualified Participants After Counseling
After counseling: All healthy women who were eligible for primary and secondary outcome measure analysis, based on the physician's assessment
Percentage of Participants With Post-counseling Contacts With Physician Offices, by Hormonal Contraceptive Method
Daily Pill (n=1199)
5.1 percentage of participants
Percentage of Participants With Post-counseling Contacts With Physician Offices, by Hormonal Contraceptive Method
Weekly Patch (n=131)
6.9 percentage of participants
Percentage of Participants With Post-counseling Contacts With Physician Offices, by Hormonal Contraceptive Method
Monthly Ring (n=397)
6.0 percentage of participants
Percentage of Participants With Post-counseling Contacts With Physician Offices, by Hormonal Contraceptive Method
Other Method (n=104)
1.9 percentage of participants
Percentage of Participants With Post-counseling Contacts With Physician Offices, by Hormonal Contraceptive Method
Undecided (n=40)
2.5 percentage of participants

Adverse Events

All Qualified Participants

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Senior Vice President, Global Clinical Development

Merck Sharp & Dohme Corp.

Results disclosure agreements

  • Principal investigator is a sponsor employee Investigators have accepted and committed not to disclose information herein contained. Investigators will not to publish or disclose any results pertaining to the study without written authorization by the Sponsor. Investigators accept that the Sponsor will review any manuscript or abstract 30 days before submission for a publication or presentation (including oral presentations) containing data derived from the present study.
  • Publication restrictions are in place

Restriction type: OTHER